Moderna and CEPI expand collaboration to include development of vaccine against Bundibugyo ebolavirus, a highly infectious and deadly virus.
Moderna and CEPI expand collaboration to include development of vaccine against Bundibugyo ebolavirus, a highly infectious and deadly virus.